ÂÜÀòÂÒÂ×

Mark Clein is a highly experienced professional who currently serves as the Co-Founder & Chief Executive Officer at Precision Medicine Group. Prior to this, Mark held various leadership roles at companies such as United BioSource Corporation and US Bioservices. Mark holds an MBA in Finance from Columbia Business School and a BA in History from the University of North Carolina at Chapel Hill.